Chemours Accused of Misleading Investors on PFAS Liabilities (1)

The Chemours Co. owes its investors hundreds of millions of dollars for concealing the true extent of its PFAS liabilities, according to a new class action filed in federal court by a pension fund for Boston electricians.

Exposure to perfluoroalkyl and polyfluoroalkyl substances is tied to a suite of health problems, including developmental complications in fetuses and young children, cancer, liver and thyroid complications, and reduced hormone and immune function.

Unsealed legal filings from the Delaware Chancery Court began to reveal that Chemours had significantly understated its potential environmental liabilities to shareholders, the Electrical Workers Pension Fund, Local 103, told ...